Guggenheim initiated coverage on Assembly Biosciences with a new price target
$ASMB
Biotechnology: Pharmaceutical Preparations
Health Care
Guggenheim initiated coverage of Assembly Biosciences with a rating of Buy and set a new price target of $31.00